HuGE Literature Finder
Records
1
-
5
Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study. Virulence 2021 1 12 (1): 270-280. Chang Ming-Ling, Lin Yu-Sheng, Chang Ming-Yu, Hsu Chia-Lin, Chien Rong-Nan, Fann Cathy |
Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism 2018 8 103 (12): 4465-4477. Nilsson Emma, Benrick Anna, Kokosar Milana, Krook Anna, Lindgren Eva, Källman Thomas, Martis Mihaela M, Højlund Kurt, Ling Charlotte, Stener-Victorin Elisab |
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovascular diabetology 2013 12 (1): 119. Saddi-Rosa Pedro, Oliveira Carolina, Crispim Felipe, Giuffrida Fernando M A, de Lima Valter, Vieira José, Doria Alessandro, Velho Gilberto, Reis And |
NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus. Clinical and experimental pharmacology & physiology 2011 Aug 38 (8): 550-4. Sheng Fei-Feng, Dai Xing-Ping, Qu Jian, Lei Guang-Hua, Lu Hong-Bin, Wu Jing, Xu Xiao-Jing, Pei Qi, Dong Min, Liu Ying-Zi, Zhou Hong-Hao, Liu Zhao-Qi |
Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population. Cytokine 2010 Jul 51 (1): 25-7. Paschou Peristera, Kukuvitis Asterios, Yavropoulou Maria P, Dritsoula Athina, Giapoutzidis Vasilios, Anastasiou Olympia, Kazakos Kyriakos, Yovos John |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: